Skip to content

Biz News Today

Business News – Direct Source News

  • Home
  • Business News Videos
    • International/National News Videos
  • Directory
  • Links PRs
  • REITS
  • About
  • Contact
    • Sitemap

Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

  • Home
  • 2019
  • June
  • 24
  • Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

Original Source

On June 24, 2019

Post navigation

Previous PostNorwegian Cruise Line Donates New Billion-Dollar Ship to Boys & Girls Clubs of Miami-Dade
Next PostNorwegian Cruise Line Announces New Immersive 2020 Itineraries

Related Post

August 12, 2022
  • Business News

Modification to the Methodology of the S&P ESG Leaders Indices

August 12, 2022
  • Business News

Modification to the Methodology of the S&P Carbon Control Index Series

August 12, 2022
  • Business News

MACOM Technology Solutions Holdings Set to Join S&P MidCap 400

Copyright © All right reserved
Newslist Created By Rise Themes

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219